Your search returned 6 results.

Results
	1.	Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction. [electronic resource] by Depta, J P Lenzini, P A Lanfear, D E Wang, T Y Spertus, J A Bach, R G Cresci, S Producer: 20150928 In: The pharmacogenomics journal vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design. [electronic resource] by Do, E J Lenzini, P Eby, C S Bass, A R McMillin, G A Stevens, S M Woller, S C Pendleton, R C Anderson, J L Proctor, P Nunley, R M Davila-Roman, V Gage, B F Producer: 20130403 In: The pharmacogenomics journal vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans. [electronic resource] by Voora, D Koboldt, D C King, C R Lenzini, P A Eby, C S Porche-Sorbet, R Deych, E Crankshaw, M Milligan, P E McLeod, H L Patel, S R Cavallari, L H Ridker, P M Grice, G R Miller, R D Gage, B F Producer: 20100416 In: Clinical pharmacology and therapeutics vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients. [electronic resource] by Lenzini, P A Grice, G R Milligan, P E Dowd, M B Subherwal, S Deych, E Eby, C S King, C R Porche-Sorbet, R M Murphy, C V Marchand, R Millican, E A Barrack, R L Clohisy, J C Kronquist, K Gatchel, S K Gage, B F Producer: 20081218 In: Journal of thrombosis and haemostasis : JTH vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. [electronic resource] by Gage, B F Eby, C Johnson, J A Deych, E Rieder, M J Ridker, P M Milligan, P E Grice, G Lenzini, P Rettie, A E Aquilante, C L Grosso, L Marsh, S Langaee, T Farnett, L E Voora, D Veenstra, D L Glynn, R J Barrett, A McLeod, H L Producer: 20080902 In: Clinical pharmacology and therapeutics vol. 84 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Integration of genetic, clinical, and INR data to refine warfarin dosing. [electronic resource] by Lenzini, P Wadelius, M Kimmel, S Anderson, J L Jorgensen, A L Pirmohamed, M Caldwell, M D Limdi, N Burmester, J K Dowd, M B Angchaisuksiri, P Bass, A R Chen, J Eriksson, N Rane, A Lindh, J D Carlquist, J F Horne, B D Grice, G Milligan, P E Eby, C Shin, J Kim, H Kurnik, D Stein, C M McMillin, G Pendleton, R C Berg, R L Deloukas, P Gage, B F Producer: 20100503 In: Clinical pharmacology and therapeutics vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)